Produce complex biomedicines

Accelerate drug development

Manufacture at lower cost

x5 to x7 yield in mammalian cells with patented
RNA polymerase C3P3®

A major shift in
biomedicines manufacturing

x5

In CHO

x7

In HEK

Compared protein production yield

Revolutionize your biomanufacturing

with Eukarys’ cutting-edge C3P3® technology, delivering unprecedented yield increases:

Save time in your clinical trials

Enable the efficient production of even your most challenging biomedicines

Reduce your costs and investments

Universal:
  • All mammalian cell lines
    Hamster (incl. CHO), human (incl. HEK-293), monkey, rat, mouse…

  • All biomedecines
    Monoclonal antibodies, N-specific antibodies, recombinant proteins, cell & gene therapy, virus-like particles, oncologic viruses…

C3P3® – your mRNA-based cells productivity booster

Based on 3 patent families, Eukarys’ revolutionary C3P3® technology is an artificial RNA polymerase performing both mRNA synthesis and mandatory post-transcriptional modifications at high yields directly in the cultured cells enabling faster and more efficient biomedicines production

Eukarys C3P3® makes your cells
hyper-productive

patent families

of the top-5 pharmaceutical companies

major research institutions

leading scientific publications

Seamless integration in your biomanufacturing process

Our C3P3® technology is designed to be easily deployed in your industrial process
  • Free from investment in new equipment
  • Maintain same biomanufacturing process
  • Full complementarity to all existing technologies
  • Proven versatility on all biologics: antibodies, proteins, VLP…
  • Preserving biologics quality: glycosylation, folding…
  • Scalability from discovery to industrial scale

Want to try our technology?

Step 1:

An exploratory call to understand your needs.

Step 2:

Validate the technology with a proof of concept on the molecules of your choice.

Step 3:

Full deployment across your biomedicines, ensuring higher yields and lower costs.

Trusted by: